Skip to main content
Log in

Neurological involvement in Erdheim–Chester disease

  • Letter to the Editor
  • Published:
Acta Neurologica Belgica Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

References

  1. Chester W (1930) Über lipoidgranulomatose. Virchows Arch Pathol Anat 279:561–602

    Article  Google Scholar 

  2. Veyssier-Belot C, Cacoub P, Caparros-Lefebvre D, Wechsler J, Brun B, Remy M et al (2004) Erdheim-Chester disease: clinical and radiologic characteristics of 59 cases. Medicine (Baltimore) 83:371–392

    Article  Google Scholar 

  3. Lachenal F, Cotton F, Desmurs-Cavel H, Haroche J, Taillia H, Magy N et al (2006) Neurological manifestations and neuroradiological presentation of Erdheim-Chester disease: report of 6 cases and systematic review of the literature. J Neurol 253:1267–1277

    Article  PubMed  Google Scholar 

  4. Mazor RD, Manevich-Mazor M, Shoenfeld Y (2013) Erdheim-Chester disease: a comprehensive review of the literature. Orphanet J Rare Dis 8:137

    Article  PubMed Central  PubMed  Google Scholar 

  5. Arnaud L, Hervier B, Neel A, Hamidou MA, Kahn JE, Wechsler B et al (2011) CNS involvement and treatment with interferon-alpha are independent prognostic factors in Erheim-Chester disease: a multicenter survival analysis of 53 patients. Blood 117:2778–2782

    Article  CAS  PubMed  Google Scholar 

  6. Drier A, Haroche J, Savatovksy J, Godeneche G, Dormont D, Chiras J et al (2010) Cerebral, facial, and orbital involvement in Erdheim-Chester disease: CT and MR imaging findings. Radiology 255:586–594

    Article  PubMed  Google Scholar 

  7. Haroche J, Arnaud L, Cohen-Aubart F, Hervier B, Charlotte F, Emile JF et al (2013) Erdheim–Chester disease. Rheum Dis Clin North Am 39:299–311

    Article  PubMed  Google Scholar 

  8. Hervier B, Arnaud L, Charlotte F, Wechsler B, Piette JC, Amoura Z et al (2012) Treatment of Erdheim-Chester disease with long-term high-dose interferon-alpha. Semin Arthritis Rheum 41:907–913

    Article  CAS  PubMed  Google Scholar 

  9. Haroche J, Cohen-Aubart F, Emile JF, Arnaud L, Maksud P, Charlotte F et al (2013) Dramatic efficacy of vemurafenib in both multisystemic and refractory Erdheim-Chester disease and Langerhans cell histiocytosis harboring the BRAF V600E mutation. Blood 12:1495–1500

    Article  Google Scholar 

Download references

Conflict of interest

On behalf of all authors, the corresponding author states that there are no conflicts of interest.

Ethical Standard

The authors declare that they acted in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki. Informed consent for publication was obtained from the patient.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jan L. De Bleecker.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Nys, E., Weynants, L., Vanneuville, B. et al. Neurological involvement in Erdheim–Chester disease. Acta Neurol Belg 115, 823–825 (2015). https://doi.org/10.1007/s13760-015-0441-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13760-015-0441-0

Keywords

Navigation